1. Home
  2. PTCT vs CLF Comparison

PTCT vs CLF Comparison

Compare PTCT & CLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • CLF
  • Stock Information
  • Founded
  • PTCT 1998
  • CLF 1847
  • Country
  • PTCT United States
  • CLF United States
  • Employees
  • PTCT N/A
  • CLF N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • CLF Metal Mining
  • Sector
  • PTCT Health Care
  • CLF Basic Materials
  • Exchange
  • PTCT Nasdaq
  • CLF Nasdaq
  • Market Cap
  • PTCT 4.8B
  • CLF 5.6B
  • IPO Year
  • PTCT 2013
  • CLF N/A
  • Fundamental
  • Price
  • PTCT $63.43
  • CLF $13.04
  • Analyst Decision
  • PTCT Buy
  • CLF Buy
  • Analyst Count
  • PTCT 14
  • CLF 11
  • Target Price
  • PTCT $67.00
  • CLF $10.74
  • AVG Volume (30 Days)
  • PTCT 1.3M
  • CLF 25.2M
  • Earning Date
  • PTCT 11-06-2025
  • CLF 10-20-2025
  • Dividend Yield
  • PTCT N/A
  • CLF N/A
  • EPS Growth
  • PTCT N/A
  • CLF N/A
  • EPS
  • PTCT 7.72
  • CLF N/A
  • Revenue
  • PTCT $1,764,929,000.00
  • CLF $18,457,000,000.00
  • Revenue This Year
  • PTCT $119.89
  • CLF $2.64
  • Revenue Next Year
  • PTCT N/A
  • CLF $5.12
  • P/E Ratio
  • PTCT $8.28
  • CLF N/A
  • Revenue Growth
  • PTCT 96.00
  • CLF N/A
  • 52 Week Low
  • PTCT $34.57
  • CLF $5.63
  • 52 Week High
  • PTCT $67.40
  • CLF $14.34
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 66.29
  • CLF 66.82
  • Support Level
  • PTCT $57.74
  • CLF $12.55
  • Resistance Level
  • PTCT $67.40
  • CLF $13.08
  • Average True Range (ATR)
  • PTCT 2.31
  • CLF 0.56
  • MACD
  • PTCT 0.16
  • CLF 0.04
  • Stochastic Oscillator
  • PTCT 62.32
  • CLF 84.08

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About CLF Cleveland-Cliffs Inc.

Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.

Share on Social Networks: